CLRB Cellectar Biosciences, Inc.
Price Chart
Executive Summary
Cellectar Biosciences filed additional definitive proxy soliciting materials (DEFA14A) for its 2026 Annual Meeting scheduled for July 7, 2026. The filing notifies stockholders of record as of May 19, 2026, and the Board recommends voting FOR all six proposals, including the election of two Class III directors (Andrew Gu and Douglas J. Swirsky), an increase in shares under the 2021 Stock Incentive Plan, ratification of Deloitte & Touche as auditor, advisory say-on-pay, approval of the exercise of warrants for up to 39,618,078 shares of common stock, and adjournment if needed to solicit additional proxies for the warrant exercise proposal. This filing follows a recent 8-K (May 18, 2026) detailing the appointment of Andrew Gu to the Board, designated by Nantahala Capital Management, and the departure of director Stefan D. Loren.
Actionable Insight
Monitor the outcome of the July 7 annual meeting, particularly Proposal 5 (warrant exercise approval) which could result in significant dilution. The appointment of Nantahala designee Andrew Gu to the Board signals activist/investor influence — watch for further strategic moves or capital allocation changes post-meeting.
Key Facts
- Annual Meeting to be held virtually on July 7, 2026
- Record date for stockholders is May 19, 2026
- Board recommends FOR all six proposals
- Proposal 1: Election of two Class III directors — Andrew Gu and Douglas J. Swirsky
- Proposal 2: Increase shares available under 2021 Stock Incentive Plan
- Proposal 3: Ratify Deloitte & Touche as independent auditor for FY2026
- Proposal 4: Non-binding advisory vote on named executive officer compensation
- Proposal 5: Approve exercise of warrants for up to 39,618,078 shares of common stock
- Proposal 6: Adjourn meeting if needed to solicit additional proxies for Proposal 5
- Cross-filing context: 8-K filed May 18, 2026, appointed Andrew Gu (Nantahala designee) to Board and disclosed departure of director Stefan D. Loren
Financial Impact
Warrant exercise proposal covers up to 39,618,078 shares of common stock, which could be highly dilutive relative to current market cap of $22M if exercised. No dollar amounts for the warrant exercise or share increase are disclosed in this filing.
Risk Factors
- Potential dilution from warrant exercise of up to 39.6 million shares
- Shareholder vote outcome uncertain — insufficient votes could delay warrant exercise proposal
- Activist investor Nantahala Capital now has Board representation, may push for strategic changes
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-067630 |
| Document: 0001104659-26-067630-index-headers.html | 0001104659-26-067630 |
| Document: 0001104659-26-067630-index.html | 0001104659-26-067630 |
| Document: 0001104659-26-067630.txt | 0001104659-26-067630 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
11d ago
|
Press Release
| $2.97 $2.59 | ▼ −12.79% | ▼ −10.04% | $2.23 (−24.92%) |
|
May 29, 2026
14d ago
|
S-1/A
| $3.14 $2.60 | ▲ +17.20% | ▲ +16.90% | $2.23 (+28.98%) |
|
May 28, 2026
15d ago
|
DEFA14A
| $3.14 $2.59 | ▼ −17.52% | ▼ −15.02% | $2.23 (−28.98%) |
|
May 19, 2026
24d ago
|
S-1
| $3.17 $3.14 | ▲ +0.95% | ▲ +2.18% | $2.23 (+29.65%) |
|
May 14, 2026
29d ago
|
8-K
| $3.20 $3.17 | ▼ −0.94% | ▼ −0.22% | $2.23 (−30.31%) |
|
May 14, 2026
29d ago
|
Press Release
| $3.20 $3.17 | ▼ −0.94% | ▼ −0.22% | $2.23 (−30.31%) |
|
May 11, 2026
4w ago
|
Press Release
| $3.06 $3.14 | ▲ +2.61% | ▲ +2.70% | $2.23 (−27.12%) |
|
May 8, 2026
5w ago
|
8-K
| $3.10 $3.20 | ▼ −3.23% | ▼ −1.76% | $2.23 (+28.06%) |
|
May 7, 2026
5w ago
|
Insider Cluster
| $3.30 $2.94 | ▲ +10.91% | ▲ +12.41% | $2.23 (+32.42%) |
|
May 6, 2026
5w ago
|
424B5
| $3.53 $2.92 | ▲ +17.28% | ▲ +18.41% | $2.23 (+36.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access